The University of Texas MD Anderson Cancer Center
OrganisationROR
People
Lead investigator
Robert A. Welch Chair in Chemistry
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Sources: openalex.org, mdanderson.org
Grants and prizes
Breast Cancer Research Foundation
Dual GLP-1/GIP Receptor Agonism for Mitigation of Aromatase Inhibitor-Induced Toxicities: A Pilot Biomarker Study, BCRF-26-231, 225k, 2026–2027, 1 Oct 2026
Targeting Early Events in Kidney Cancer - Integrating metabolism and immune surveillance for prevention, ACPA-26-1601996-01-ACS CRUK W25, 928k, 2026–2031, 1 Aug 2026
Cancer Prevention and Research Institute of Texas
Academic Research, Impact of Patient Fitness and Biological Aging on Outcomes for Multiple Myeloma treated with BCMA T-Cell Redirection Therapy, RP260128, US$894.1k, 2025, 19 Nov 2025
Cancer Prevention and Research Institute of Texas
Prevention, Self-collection, Capacity Building, and Resources to Enhance Cervical Cancer Screening and Navigation to Care for the Unhoused Population (SCREEN-UP), PP260042, US$1.1m, 2025, 19 Nov 2025
Cancer Prevention and Research Institute of Texas
Prevention, Maintenance of Project ACCESS: Increasing Access to Cervical Cancer Screening & Treatment Services in Texas, PP260030, US$2.5m, 2025, 19 Nov 2025
Cancer Prevention and Research Institute of Texas
Academic Research, Clonal hematopoiesis and toxicity from radiation therapy, RP250062, US$899.9k, 2025, 19 Feb 2025
Cancer Prevention and Research Institute of Texas
Prevention, A Virtual, Centralized Lung Cancer Screening Program for Northeast Texas, PP250004, US$1.5m, 2024, 20 Nov 2024
Cancer Prevention and Research Institute of Texas
Prevention, Project 80% Colorectal Cancer Screening Program, PP250005, US$2.5m, 2024, 20 Nov 2024
Cancer Prevention and Research Institute of Texas
Prevention, Expanding Access to Cervical Cancer Screening through Primary HR-HPV Testing and Self-Sampling: A Multicomponent Intervention for Safety Net Health Systems, PP240017, US$2.5m, 2024, 21 Feb 2024
IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) intervention, AHEAD-DBG-23-1143580-01-CPSH, 300k, 2024–2025, 1 Jan 2024
Cancer Prevention and Research Institute of Texas
Academic Research, Geospatial Approaches to Melanoma Early Detection - The GAMED Project, RP230036, US$2m, 2023, 15 Feb 2023
Cancer Prevention and Research Institute of Texas
Prevention, Taking Texas Tobacco Free: Dissemination to and Implementation within Lung Cancer Screening Programs, PP230002, US$448.7k, 2023, 15 Feb 2023
Cancer Prevention and Research Institute of Texas
Academic Research, Multi-component Interventions to Improve Uptake and Adherence to Lung Cancer Screening, RP230213, US$2m, 2023, 15 Feb 2023
Cancer Prevention and Research Institute of Texas
Academic Research, Reversing Aging Associated Resistance to Cancer Immunotherapy, RP220553, US$250k, 2022, 14 Sept 2022
Cancer Prevention and Research Institute of Texas
Prevention, Project ACCESS: Increasing Access to Cervical Cancer Screening & Treatment Services in Texas, PP220037, US$2.5m, 2022, 17 Aug 2022
Cancer Prevention and Research Institute of Texas
Prevention, Strengthening Safety Net Health Systems to Improve Cervical and Colorectal Cancer Screening and Follow-up among the Medically Underserved, PP210007, US$1.8m, 2021, 18 Aug 2021
Cancer Prevention and Research Institute of Texas
Academic Research, Improving the Quality of Smoking Cessation and Shared Decision-Making for Lung Cancer Screening: A Cluster Randomized Trial, RP190210, US$1.5m, 2019, 21 Feb 2019
Patient-Centered Outcomes Research Institute
Implementation Project (Limited Competition D&I PFA), Putting Patient Decision Support in Place for Lung Cancer Screening through Tobacco Quitlines, pcori-putting-patient-decision-support-place-lung-cancer-screening-through-tobacco-quitlines, US$1.2m, 2019, 1 Jan 2019
Circulating Exosomes as Biomarkers for Lung Cancer Early Detection, 130144 - RSG-18-001-01-TBG, 792k, 2018, 1 Mar 2018
Cancer Prevention and Research Institute of Texas
Academic Research, Blood-based biomarkers for the early detection of pancreatic cancer, RP180607, US$900k, 2018, 21 Feb 2018
Sources: openalex.org
Funded papers
A blood-based metabolic signature for earlier detection of lung cancer
23 Sept 2026
Exercise-associated epigenetic remodeling and TCR repertoire dynamics in Lynch syndrome carriers
28 Aug 2026
Sources: api.crossref.org